Eplerenone for Central Serous Chorioretinopathy
NCT01822561
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Central Serous Chorioretinopathy
Interventions
DRUG:
Eplerenone 50mg
Sponsor
Tufts Medical Center